Vaccines are the subject of a record skepticism on the part of the French, whose distrust also increases for most classes of drugs, and to health professionals, according to an annual study released Monday.
The recent health scandals have made the French wary of vaccines . Only 69% of respondents trust them (-2 points compared to 2015), according to a study Annual published Monday.
This is the lowest rate since the launch of the “societal Observatory drug ” produced since 2012 by Ipsos on behalf of the French organization of the industrial sector, Leem.
One in three French estimated that there are so many benefits than risks
Furthermore, only half (52%) of respondents consider that the vaccination has more benefits than risks, 33% believing that it includes both the two and 15% more risks than benefits, according to the study . These perceptions, however, vary from one generation to another generation of 25-34 years and is the most suspicious of vaccines, and that of the more confident 55-59.
Of all respondents, 34% say they are not certain to be current in their vaccinations and 6% have no idea.
Several controversies surrounding vaccines in recent years, including the vaccine against hepatitis B , vaccines against infections with human papillomavirus (HPV), the cause of genital cancers, or the vaccine against pandemic influenza A (H1N1 ) in 2009 . in an attempt to remedy this, a “citizen dialogue” on vaccines was launched this year by the Ministry of health with the general public and professional health . A summary and recommendations are expected before the end of the year.
Only homeopathy increased (73%, +2 points), while generic remained stable compared to 2015, to 68%.
Trust in health professionals for information on medicines also remains high (88% for pharmacists to 93% for the practicing doctor) but declines year on year, while that given to whistle blowers explodes (69% +24 points).
The survey was conducted among a representative sample of 1 000 people in France, interviewed by internet from 9 to 16 June 2016.
